122 related articles for article (PubMed ID: 38117565)
1. An Alternative to Cytology in Triaging Cisgender Men and Transgender Women With HIV for High-Resolution Anoscopy.
Mudrinich SM; Nguyen MLT; Blemur DM; Wang X; Wang YF; Krishnamurti U; Mosunjac M; Flowers LC
J Low Genit Tract Dis; 2024 Jan; 28(1):101-106. PubMed ID: 38117565
[TBL] [Abstract][Full Text] [Related]
2. Comparing Anal Cancer Screening Algorithms Using Cytology and Human Papillomavirus DNA Testing in 3 High-Risk Populations.
Gaisa MM; Sigel KM; Deshmukh AA; Lenskaya V; Chan CA; Silvera R; Winters J; Liu Y
J Infect Dis; 2021 Sep; 224(5):881-888. PubMed ID: 33388757
[TBL] [Abstract][Full Text] [Related]
3. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia.
Berry JM; Palefsky JM; Jay N; Cheng SC; Darragh TM; Chin-Hong PV
Dis Colon Rectum; 2009 Feb; 52(2):239-47. PubMed ID: 19279418
[TBL] [Abstract][Full Text] [Related]
4. Automated Evaluation of p16/Ki-67 Dual-Stain Cytology as a Biomarker for Detection of Anal Precancer in Men Who Have Sex With Men and Are Living With Human Immunodeficiency Virus.
Cohen CM; Wentzensen N; Lahrmann B; Tokugawa D; Poitras N; Bartels L; Krauthoff A; Keil A; Miranda F; Castle PE; Lorey T; Hare B; Darragh TM; Grabe N; Clarke MA
Clin Infect Dis; 2022 Oct; 75(9):1565-1572. PubMed ID: 35325073
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.
Zhang J; Zhao Y; Dai Y; Dang L; Ma L; Yang C; Li Y; Kong L; Wei L; Zhang S; Liu J; Xi M; Chen L; Duan X; Xiao Q; Abulizi G; Zhang G; Hong Y; Gao X; Zhou Q; Xie X; Li L; Niyazi M; Zhang Z; Tuo J; Ding Y; Si M; Chen F; Song L; Qiao Y; Lang J
JAMA Oncol; 2021 Feb; 7(2):263-270. PubMed ID: 33377903
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
7. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
[TBL] [Abstract][Full Text] [Related]
8. BD-ProExC as adjunct molecular marker for improved detection of CIN2+ after HPV primary screening.
Depuydt CE; Makar AP; Ruymbeke MJ; Benoy IH; Vereecken AJ; Bogers JJ
Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):628-37. PubMed ID: 21297040
[TBL] [Abstract][Full Text] [Related]
9. Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy.
Dijkstra MG; van Niekerk D; Rijkaart DC; van Kemenade FJ; Heideman DA; Snijders PJ; Meijer CJ; Berkhof J
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):55-63. PubMed ID: 23733907
[TBL] [Abstract][Full Text] [Related]
10. Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV.
Chiao EY; Lensing SY; Wiley DJ; Deshmukh AA; Lee J; Darragh TM; Einstein MH; Jay N; Berry-Lawhorn JM; Palefsky JM; Wilkin T; Barroso LF; Cranston RD; Levine R; Guiot HM; French AL; Citron D; Rezaei MK; Goldstone SE; Stier EA
AIDS; 2020 Dec; 34(15):2249-2258. PubMed ID: 32947592
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women.
Del Mistro A; Frayle H; Ferro A; Callegaro S; Del Sole A; Stomeo A; Cirillo E; Fedato C; Pagni S; Barzon L; Zorzi M;
J Med Screen; 2014 Mar; 21(1):30-7. PubMed ID: 24488593
[TBL] [Abstract][Full Text] [Related]
12. The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.
Ebisch RM; de Kuyper-de Ridder GM; Bosgraaf RP; Massuger LF; IntHout J; Verhoef VM; Heideman DA; Snijders PJ; Meijer CJ; van Kemenade FJ; Bulten J; Siebers AG; Bekkers RL; Melchers WJ
Int J Cancer; 2016 Aug; 139(3):691-9. PubMed ID: 26991464
[TBL] [Abstract][Full Text] [Related]
13. Reflex cytology for triage of high-risk human papillomavirus positive self-sampled material in cervical cancer screening: a prospective cohort study.
Loopik DL; Melchers W; Vedder J; van den Brule A; Massuger L; Bekkers R; Siebers AG
BJOG; 2020 Dec; 127(13):1656-1663. PubMed ID: 32506627
[TBL] [Abstract][Full Text] [Related]
14. 5-Year Prospective Evaluation of Cytology, Human Papillomavirus Testing, and Biomarkers for Detection of Anal Precancer in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men.
Clarke MA; Cheung LC; Lorey T; Hare B; Landy R; Tokugawa D; Gage JC; Darragh TM; Castle PE; Wentzensen N
Clin Infect Dis; 2019 Aug; 69(4):631-638. PubMed ID: 30418518
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
Dong L; Wang MZ; Zhao XL; Feng RM; Hu SY; Zhang Q; Smith JS; Qiao YL; Zhao FH
Gynecol Oncol; 2018 Jan; 148(1):103-110. PubMed ID: 29169614
[TBL] [Abstract][Full Text] [Related]
16. Performance of anal cytology in a clinical setting when measured against histology and high-resolution anoscopy findings.
Nathan M; Singh N; Garrett N; Hickey N; Prevost T; Sheaff M
AIDS; 2010 Jan; 24(3):373-9. PubMed ID: 20057313
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus test in anal smears: can it optimize the screening for anal cancer?
Kimura CMS; Nahas CSR; Silva-Filho EV; Ribeiro VL; Segurado AC; Alcântara FFP; Cecconello I; Nahas SC
AIDS; 2021 Apr; 35(5):737-745. PubMed ID: 33306557
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
